Clinical Trials Directory

Trials / Completed

CompletedNCT03205306

Myasthenia Gravis and Psyche

Status
Completed
Phase
Study type
Observational
Enrollment
1,399 (actual)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to systematically capture and characterize mental comorbidities for patients with myasthenia gravis. Anxiety disorders and depression for example, can negatively affect the quality of life and lead to e.g. unemployment and early retirement especially in young patients. Additionally the researchers want to find out in what way certain aspects of the disease have an influence on the quality of life, and whether different concepts of coping with the disease have different effects on the quality of life for patients with myasthenia gravis. During the study, close relatives of patients will also be asked to provide input about their current stress situation in the context of supporting their relative. Based on the results, the investigators want to improve and supplement established treatment concepts, to ensure a more comprehensive and individual treatment.

Conditions

Timeline

Start date
2017-05-08
Primary completion
2017-12-14
Completion
2017-12-14
First posted
2017-07-02
Last updated
2023-01-10

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03205306. Inclusion in this directory is not an endorsement.

Myasthenia Gravis and Psyche (NCT03205306) · Clinical Trials Directory